Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose–response relationships

https://doi.org/10.1016/j.mrgentox.2010.08.020Get rights and content

Abstract

This laboratory has developed a flow cytometric approach for scoring in vitro micronuclei (In Vitro MicroFlow®) whose characteristics are expected to benefit studies designed to comprehensively investigate genotoxicity dose–response relationships. In particular, new experimental designs become possible when automated scoring is combined with treatment, processing and sampling that all occur in microtiter plates. To test this premise, experiments described herein investigated micronucleus (MN) formation in TK6 cells treated with genotoxic agents applied at 22 closely spaced concentrations in quadruplicate, with 10,000 cells analyzed per replicate. The genotoxicants colchicine, vinblastine sulfate, ethyl methanesulfonate, methyl methanesulfonate, ethyl nitrosourea, methyl nitrosourea, and bleomycin were applied continuously for 24–30 h. Following treatment, all cell processing, sampling and data acquisition steps were accomplished in the same 96-well plate. Data acquisition occurred in a walk-away mode via the use of a high throughput sampling device. The resulting flow cytometric MN values were evaluated with a statistical model that indicated non-linear relationships describe the data better than linear fits. The one exception was bleomycin, where MN induction was consistently best described by a linear dose–response relationship. Collectively, these results suggest that flow cytometry represents a practical and efficient approach for thoroughly examining the dose–response relationship, and clearly benefits studies that seek to characterize no observable genotoxic effect levels, lowest observable genotoxic effect levels, and/or benchmark doses.

Introduction

The existence of a threshold dose, that is, a dose level below which no-observed-adverse effects occur, is a well-known concept in toxicology [1]. For certain classes of genotoxicants, primarily aneugens, there is general consensus that their dose–response relationships are thresholded [2], [3], [4]. The mode of action for these agents is considered a key variable. For instance in the case of spindle poisons, chromosome segregation is not affected unless multiple targets are disrupted, a situation that is predicted to result in a thresholded response [5]. Conversely, radiation and DNA-reactive gentoxicants have historically been assumed to exhibit non-thresholded dose–response relationships [6], [7]. This default assumption has important consequences, since by definition there is no dose without effect. Regulation of genotoxicants with this profile is therefore strict in order to prevent or at least minimize human exposure [8], [9]. However, new evidence is accumulating that suggests even DNA-reactive genotoxicants can exhibit thresholded dose–responses [10], [11], [12], [13], [14]. Cellular defenses mechanisms, especially DNA-repair capacity, are often cited as contributing to thresholds in these cases [15].

Given the important implications that dose–response relationships have in risk assessment, it is clear that assumptions about DNA-reactivity/non-reactivity and thresholded versus non-thresholded responses requires further study. This situation highlights the need for in vitro assays that can comprehensively evaluate the low end of the dose–response curve. Indeed, Johnson et al. [12] expressed the need for in vitro assays that allow for large numbers of individual cells to be analyzed, include many replicates, and utilize closely spaced dose levels. However, the desire for thorough dose–response data is problematic unless the assay is very efficient, with data acquisition occurring via an automated process.

This laboratory has previously reported on the development of a flow cytometric method for scoring in vitro micronuclei (commercially known as In Vitro MicroFlow®) [16], [17], [18]. In this system, a non-ionic detergent is used to liberate nuclei and micronuclei into suspension. In conjunction with outer membrane lysis, a sequential staining procedure is used to differentially stain chromatin from dead and dying cells from that of “healthy cells”, thereby minimizing the impact that necrosis and apoptosis has on the micronucleus (MN) frequency determinations. The so-called miniaturized version of the assay, conducted in 96-well plates, exhibits several characteristics that address the requirements articulated by Johnson et al. For instance, all the cell processing steps occur in the same 96-well plate, thus enhancing assay efficiency. In this format, it becomes simple to examine a very large number of concentrations and to include many replicate wells. Furthermore, flow cytometric data acquisition allows one to interrogate many cells per replicate for MN formation. We hypothesized that these characteristics would provide a useful platform for studying genotoxicity dose–response relationships. To test this premise, we used this system to study several prototypical genotoxicants, both DNA-reactive and non-reactive, using many finely spaced dose levels. The resulting data were evaluated in a statistical model designed to estimate a threshold dose and its confidence limits [19]. The results are discussed in regards to the ongoing need for data that thoroughly evaluates dose–response relationships.

Section snippets

Reagents

Colchicine (COL), vinblastine sulfate (VB), ethyl methanesulfonate (EMS), methyl methanesulfonate (MMS), ethyl nitrosourea (ENU), methyl nitrosourea (MNU), bleomycin (BLEO), and dimethyl sulfoxide (DMSO) were purchased from Sigma–Aldrich (St. Louis, MO). Reagents for staining and lysing cells for flow cytometric analysis were from In Vitro MicroFlow® Kits (Litron Laboratories, Rochester, NY). These materials included Buffer Solution, Nucleic Acid Dye A Solution (i.e., ethidium monoazide

Preliminary experiments

Results from two independent reconstruction experiments performed with latex microspheres are shown in Fig. 3 and Table 2. Importantly, the density and incidence of the latex microspheres were carefully chosen to simulate the occurrence of nuclei and MN evaluated in the cell-based work that followed. With high p-values as well as zero values for the lower limit of the threshold confidence interval, the hockey stick model indicated that these data sets are best described by linear fits. These

Discussion

Elucidation of dose–response relationships at relatively low concentrations can have significant implications for risk assessment, and new tools and techniques for conducting these investigations are needed [9], [12]. We undertook these proof-of-principle studies with a flow cytometry-based MN scoring system, realizing its throughput capacity has the potential to enhance the experimental design, especially in terms of numbers concentrations, replicate wells, and cells scored. To begin examining

Conflict of interest

The authors are employed by Litron Laboratories, a company that holds patents related to flow cytometry-based micronucleus scoring. Litron sells kits based on this technology that are commercially known as In Vitro MicroFlow® Kits.

Acknowledgments

This work was funded by a grant from the National Institute of Health/National Institute of Cancer (S.D.D., No. R44CA117093). The contents are solely the responsibility of the authors, and do not necessarily represent the official views of the NCI.

References (25)

Cited by (49)

  • Evaluation of genotoxic potential of peptides used in nuclear medicine (PSMA -617 and -11, and ubiquicidine 29-41) using a flow-cytometric, semi-automated analysis of micronuclei frequency in cell cultures

    2020, Toxicology Reports
    Citation Excerpt :

    After 4 or 24 h, the culture medium from the CC wells and negative controls was removed and the cells received fresh culture medium. The procedure followed the protocol described elsewhere [5,20,21]. After 72 h in culture, the cells seeded in 96-well plates irradiated or in concentrations with the drugs, as well as those treated with the described genotoxic agents, were centrifuged (1500 RPM in 10 min) and received a solution of ethidium monoazide bromide (Thermo-Fisher Scientific, E1374) at a concentration of 8.5 μg/mL diluted in PBS supplemented with 2 % fetal bovine serum.

  • Development of an integrated assay in human TK6 cells to permit comprehensive genotoxicity analysis in vitro

    2020, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
    Citation Excerpt :

    In addition, the test system of any assay under development or refinement is nowadays scrutinized for appropriateness [30,36]. In this case, we selected the TK6 cell line as the ideal test system owing to its: (a) human origin with known provenance (particularly in the case of the IVGT clone), chromosomal stability, and proficiency in cellular defense mechanisms [30]; (b) accepted status for use in in vitro mammalian genetic toxicology studies by the OECD [32,35]; (c) amenability to genotoxicity analysis via standardized test protocols (i.e., OECD TGs 487 and 490 and MultiFlow® and MicroFlow® instructions) [31,32,35,37]; and (d) widespread use in key genetic toxicology laboratories around the world, resulting in a rich supply of benchmark data as well as the development of universal GEFs for each MoA endpoint [22,31,38,39]. Several prototypical direct-acting genotoxins and pro-genotoxins were assessed in the integrated assay and found to elicit genotoxic profiles that were generally consistent with their MoA.

  • Integrated in silico and in vitro genotoxicity assessment of thirteen data-poor substances

    2019, Regulatory Toxicology and Pharmacology
    Citation Excerpt :

    Contemporary genotoxicity assessment approaches frequently include an initial screen using in silico quantitative structure-activity relationship ((Q)SAR) models followed by in vitro testing (Hughes et al., 2009; Mahadevan et al., 2011; Myatt et al., 2018). Two commonly used in vitro genotoxicity tests are the bacterial reverse mutation test (Ames assay) and the in vitro micronucleus test (MN) (Bryce et al., 2010; Claxton et al., 2010; Kirkland et al., 2011). Together, the combination of these in silico and in vitro tests can be used to evaluate the weight-of-evidence for the genotoxic hazard of a chemical.

  • The potential for complete automated scoring of the cytokinesis block micronucleus cytome assay using imaging flow cytometry

    2018, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
    Citation Excerpt :

    One major drawback of this technique however, was the inability to distinguish MN from the chromatin of necrotic and mid/late apoptotic bodies. To address these issues, Litron Laboratories expanded the original method, using EMA to identify and differentiate necrotic and apoptotic bodies from free-floating SYTOX Green-stained nuclei and MN in suspension in mouse lymphoma (L5178Y) cells and human lymphoblast (TK6) cells [28–32]. The two main limitations to adapting this method to the CBMN Cyt assay stem from the absence of Cyt-B in cell cultures and the requirement to lyse cells in order to liberate the main nuclei and MN.

  • Drug discovery technologies: Current and future trends

    2017, Comprehensive Medicinal Chemistry III
View all citing articles on Scopus
View full text